Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James F Howard

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Muscle & Nerve|April 22, 2025
Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice: A Report of the MGFA Task ForceKatherine Ruzhansky, Yuebing Li, Gil I Wolfe, et al.
Neuromuscular Disorders : NMD|May 21, 2022
Selected clinical and demographic factors and all-cause mortality among individuals with Duchenne muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking, and Research NetworkPangaja Paramsothy, Yinding Wang, Bo Cai, et al.
Annals of Clinical and Translational Neurology|March 16, 2023
Clinicoserological insights into patients with immune checkpoint inhibitor-induced myasthenia gravisGianvito Masi, Minh C Pham, Tabitha Karatz, et al.
Experimental Neurology|November 26, 2018
Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patientsYingkai Li, Jeffrey T Guptill, Melissa A Russo, et al.
The New England Journal of Medicine|April 9, 2025
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia GravisRichard J Nowak, Michael Benatar, Emma Ciafaloni, et al.
Journal of Neuromuscular Diseases|March 11, 2022
Role Attainment in Emerging Adulthood: Subjective Evaluation by Male Adolescents and Adults with Duchenne and Becker Muscular DystrophyHolly L Peay, Barbara T Do, Neil Khosla, et al.
Autoimmunity|September 30, 2016
Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravisJeffrey T Guptill, Vern C Juel, Janice M Massey, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 7, 2015
Characterization of B cells in muscle-specific kinase antibody myasthenia gravisJeffrey T Guptill, John S Yi, Donald B Sanders, et al.
Pediatric Neurology|May 29, 2024
Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter StudyJohn F Brandsema, Matthew Ginsberg, Hideki Hoshino, et al.
Journal of Neuroimmunology|June 5, 2020
Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravisYingkai Li, Jeffrey T Guptill, Melissa A Russo, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Muscle & Nerve|April 22, 2025
Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice: A Report of the MGFA Task ForceKatherine Ruzhansky, Yuebing Li, Gil I Wolfe, et al.
Neuromuscular Disorders : NMD|May 21, 2022
Selected clinical and demographic factors and all-cause mortality among individuals with Duchenne muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking, and Research NetworkPangaja Paramsothy, Yinding Wang, Bo Cai, et al.
Annals of Clinical and Translational Neurology|March 16, 2023
Clinicoserological insights into patients with immune checkpoint inhibitor-induced myasthenia gravisGianvito Masi, Minh C Pham, Tabitha Karatz, et al.
Experimental Neurology|November 26, 2018
Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patientsYingkai Li, Jeffrey T Guptill, Melissa A Russo, et al.
The New England Journal of Medicine|April 9, 2025
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia GravisRichard J Nowak, Michael Benatar, Emma Ciafaloni, et al.
Journal of Neuromuscular Diseases|March 11, 2022
Role Attainment in Emerging Adulthood: Subjective Evaluation by Male Adolescents and Adults with Duchenne and Becker Muscular DystrophyHolly L Peay, Barbara T Do, Neil Khosla, et al.
Autoimmunity|September 30, 2016
Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravisJeffrey T Guptill, Vern C Juel, Janice M Massey, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 7, 2015
Characterization of B cells in muscle-specific kinase antibody myasthenia gravisJeffrey T Guptill, John S Yi, Donald B Sanders, et al.
Pediatric Neurology|May 29, 2024
Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter StudyJohn F Brandsema, Matthew Ginsberg, Hideki Hoshino, et al.
Journal of Neuroimmunology|June 5, 2020
Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravisYingkai Li, Jeffrey T Guptill, Melissa A Russo, et al.
Pageof 12